Blue Trust’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
Blue Trust's NVO Position: Q3 2026 in Review
Blue Trust reduced its Novo Nordisk (NVO) stake by 65% in Q3 2026, selling an estimated $219K and leaving 2,521 shares worth $95.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1019.
Blue Trust first reported a position in NVO in Q2 2022 and has held it in 18 quarters since. The position peaked at $3.24M in Q3 2024. 1,075 funds tracked by Wall St. Rank hold NVO as of Q3 2026.
- Blue Trust held 2,521 shares of Novo Nordisk worth $95.6K as of Q3 2026.
- Blue Trust sold 4,741 Novo Nordisk shares in Q3 2026, an estimated $219K.
- Novo Nordisk made up ﹤0.01% of Blue Trust's portfolio in Q3 2026, its #1019 holding.
- Blue Trust first reported a position in Novo Nordisk in Q2 2022 and has held it in 18 quarters since.
- Blue Trust's Novo Nordisk position peaked at $3.24M in Q3 2024.
- 1,075 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.
Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.